Procter & Gamble Co Chief Financial Officer Andre Schulten filed a Form 4 on November 5, 2026, disclosing the exercise of stock options and a same-day sale of common stock that occurred on November 4, 2026.

Key Highlights

  • Option exercise: Schulten acquired 33,624 shares of common stock on November 4, 2026, via a stock option exercise (transaction code M) at a conversion price of $91.07 per share.
  • Same-day sale: Schulten disposed of 33,624 shares on November 4, 2026, at a price of $165 per share (transaction code S).
  • Direct ownership after transactions: Following the reported transactions, Schulten directly held 65,618.0097 shares of common stock.
  • Indirect holdings: An additional 7,604.419 shares are held indirectly by a retirement plan trustee.
  • Options extinguished: The exercised stock option, with an expiration date of February 26, 2027, carried zero remaining derivative securities after the transaction.
  • Role: Schulten is identified in the filing as Chief Financial Officer of Procter & Gamble Co (NYSE:PG).

Schulten's November 4 Option Exercise and Stock Sale at Procter & Gamble

According to the Form 4 filed with the SEC on November 5, 2026, Andre Schulten, Chief Financial Officer of Procter & Gamble Co (NYSE:PG), exercised a stock option on November 4, 2026, acquiring 33,624 shares of common stock at the option's conversion price of $91.07 per share. The option was originally exercisable as of February 28, 2020, and was set to expire on February 26, 2027. Following the exercise, the filing reports zero remaining derivative securities in that option grant.

On the same date, the filing discloses that Schulten disposed of 33,624 shares at a price of $165 per share, identified as a sale (transaction code S). After these two transactions, Schulten's direct beneficial ownership of Procter & Gamble common stock stood at 65,618.0097 shares, according to the filing. An additional 7,604.419 shares are reported as held indirectly through a retirement plan trustee.

The Form 4 was signed by Jennifer DollardSmith as attorney-in-fact for Andre Schulten and was filed on November 5, 2026. The filing does not indicate that any transaction was made pursuant to a Rule 10b5-1(c) written plan, as that checkbox is not marked.

What Was Disclosed

Procter & Gamble CFO Andre Schulten reported the exercise of 33,624 stock options at $91.07 and the sale of 33,624 shares at $165 on November 4, 2026, leaving direct holdings of 65,618.0097 shares and indirect holdings of 7,604.419 shares via a retirement plan trustee.